Taiwan FDA registration a59c6961fe11ec84131aa41fe19e6afb

Bott blood glucose testing system

TW: 博特血糖測試系統

Taiwan·Risk Class 2·Weiren Technology Co., Ltd.; Ruizhi Biochemical Technology Co., Ltd·Registered Jun 21, 2019 – Jun 21, 2029Active

Registration details

Analysis ID: a59c6961fe11ec84131aa41fe19e6afb

Company information

Manufacturer: Weiren Technology Co., Ltd.; Ruizhi Biochemical Technology Co., Ltd
Manufacturer Country: Taiwan, Province of China
Authorized Representative: WELLAN TECH CO., LTD.

Product details

Intended Use: This product can be quantitatively measured by fresh veins or fingertip whole blood and can be used by diabetics or healthcare professionals.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1345 Glucose Test System
Import Information: 委託製造;; QMS/QSD;; 國產

Dates and status

Registration Date: Jun 21, 2019
Expiry Date: Jun 21, 2029

About this record

Access comprehensive regulatory information for Bott blood glucose testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a59c6961fe11ec84131aa41fe19e6afb and manufactured by Weiren Technology Co., Ltd.; Ruizhi Biochemical Technology Co., Ltd. The authorized representative in Taiwan is WELLAN TECH CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.